Companies › SCTX

SCTX 10-K & 10-Q changes, risk factors and insider trading

Scribe Therapeutics, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances) · CIK 1853921 · All filings on SEC.gov

Everything below is quoted or computed from Scribe Therapeutics, Inc.'s public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

6Form 4 filings reporting open-market purchases (last 180 days)
0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare..

What changed in the latest 10-Q

Comparison not available: Not available: fewer than two 10-Q filings on EDGAR to compare (only one so far)..

SCTX insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 6 Form 4 filings (6 insiders, 4 trade dates, 4,728,904 shares, about $71.3M) and open-market sales in 0 filings. Net open-market shares: 4,728,904 (purchases minus sales); net value about $71.3M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

Trade dateInsiderTransactionSharesPriceValueOwned afterFiling
2026-07-28Avoro Ventures Llc
Director, See Remarks		 Open-market purchase 7,905$18.25 $144.3K3,088,888 SEC
2026-07-27Ah Equity Partners Bio Ii, L.l.c.
10% owner		 Open-market purchase 333,333$15.00 $5.0M2,385,075 SEC
2026-07-27Ah Equity Partners Bio Ii, L.l.c.
10% owner		 Conversion 697,650— —697,650 SEC
2026-07-27Ah Equity Partners Bio Ii, L.l.c.
10% owner		 Conversion 2,051,742— —2,051,742 SEC
2026-07-27Gordon Carl L
Director		 Open-market purchase 1,000,000$15.00 $15.0M1,348,825 SEC
2026-07-27Gordon Carl L
Director		 Conversion 348,825— —348,825 SEC
2026-07-27Orbimed Advisors Llc
Director		 Open-market purchase 1,000,000$15.00 $15.0M1,348,825 SEC
2026-07-27Orbimed Advisors Llc
Director		 Conversion 348,825— —348,825 SEC
2026-07-27Doudna Jennifer A
10% owner		 Conversion 12,511— —603,547 SEC
2026-07-24Avoro Ventures Llc
Director, See Remarks		 Open-market purchase 50,000$22.31 $1.1M3,080,983 SEC
2026-07-24Avoro Ventures Llc
Director, See Remarks		 Open-market purchase 2,333,333$15.00 $35.0M3,030,983 SEC
2026-07-23Lucas Svetlana
Chief Business Officer		 Open-market purchase 3,000$15.00 $45.0K3,000 SEC
2026-07-23Parrot David
Chief Financial Officer		 Open-market purchase 1,333$15.00 $20.0K1,333 SEC

Well-known investors holding SCTX (13F)

None of the 59 investors we track reported a position in their latest 13F.

Coming soon: email alerts when SCTX files, watchlists and downloadable comparisons.